Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 23, 2004

View Archived Issues

First report of selective epsilon opioid receptor agonist

Role of oleamide and anandamide in food intake and sexual behavior in rats

Cephalon completes acquisition of CIMA Labs

Novel parenteral carbapenem against multidrug-resistant bacteria

Endo closes agreement to market Frova in North America

Macugen NDA accepted for review

Karo Bio continues progress across several research areas

Bivalent ligand selectively targets spinal cord delta-kappa heterodimers

Multichannel blocker attenuates arrhythmia and cardiac failure

Eisai presents novel SERM derivatives

Selective prostaglandin D2 receptor antagonist for the treatment of allergic rhinitis

Arena claims new 5-HT2A receptor modulators and their therapeutic use

New HGF modulators prepared and tested at Angion Biomedica

Novel PDE4 inhibitors in early development at Almirall Prodesfarma

Artesian researchers claim dual beta-AR/PDE3 inhibitors

New EGFR inhibitors identified by Ariad scientists

Two series of histamine H3 antagonists/inverse agonists designed at GSK

Dual NK1 antagonists/5-HT reuptake inhibitors presented by AstraZeneca

New phase I/II study of CG-7870 plus Taxotere for prostate cancer

Antigen Express and Massachusetts General Hospital collaborate in HIV

MedImmune advances IL-9 monoclonal antibody into new phase I study

SBIR grant supports development of improved interferon beta analogues

BioPort IND accepted for anthrax immunity stimulating molecule

Taxotere approved for early-stage breast cancer

Viventia Biotech and Acceptys enter option agreement for anticancer antibodies

Protox Therapeutics retains CTBR for preclinical testing of PSA-PA1

Abbott presents results of a neuronal nicotinic receptor agonist with analgesic activity

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...